Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.

Using an experimental endocarditis model, we studied the activity of daptomycin used alone or in combination with gentamicin against an Enterococcus faecium strain that was highly resistant to glycopeptides and susceptible to gentamicin. In vitro, the MIC of daptomycin was 1 micrograms/ml. In vivo,...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Antimicrob Agents Chemother
Asıl Yazarlar:	Caron, F, Kitzis, M D, Gutmann, L, Cremieux, A C, Maziere, B, Vallois, J M, Saleh-Mghir, A, Lemeland, J F, Carbon, C
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1992
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245515/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1336339/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2611
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.

Benzer Materyaller